Related references
Note: Only part of the references are listed.Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Lei Pan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Clinical Insights into the Gastrointestinal Manifestations of COVID-19
Jonathan Kopel et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
COVID-19 and gastrointestinal endoscopies: Current insights and emergent strategies
Abhilash Perisetti et al.
DIGESTIVE ENDOSCOPY (2020)
Taste Changes (Dysgeusia) in COVID-19: A Systematic Review and Meta-analysis
Muhammad Aziz et al.
GASTROENTEROLOGY (2020)
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2020)
COVID-19 presenting as acute pancreatitis
Mark M. Aloysius et al.
PANCREATOLOGY (2020)
Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2
Chiranjeevi Gadiparthi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients
Preethi Ramachandran et al.
DIGESTIVE DISEASES (2020)
Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis
Umesha Boregowda et al.
FRONTIERS IN MEDICINE (2020)
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
Kemmian D. Johnson et al.
FRONTIERS IN MEDICINE (2020)
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19
Jeffrey F. Mather et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
Christopher Almario et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Gut microbiota and Covid-19-possible link and implications
Debojyoti Dhar et al.
VIRUS RESEARCH (2020)
Could the severity of COVID-19 be increased by low gastric acidity?
Elizabeth Price
CRITICAL CARE (2020)
Interactions of bile acids and the gut microbiota: learning from the differences in Clostridium difficile infection between children and adults
Sijing Cheng et al.
PHYSIOLOGICAL GENOMICS (2019)
New and emerging therapies in treatment of Clostridium difficile infection
Hemant Goyal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
Yan Xie et al.
BMJ OPEN (2017)
Proton pump inhibitors alter the composition of the gut microbiota
Matthew A. Jackson et al.
GUT (2016)
Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea
Lukas Buendgens et al.
JOURNAL OF CRITICAL CARE (2014)
Histamine-2 Receptor Antagonists vs Proton Pump Inhibitors on Gastrointestinal Tract Hemorrhage and Infectious Complications in the Intensive Care Unit
Robert MacLaren et al.
JAMA INTERNAL MEDICINE (2014)
Role of Prophylactic Pre-Esophagogastroduodenoscopy (EGD) Endotracheal Intubation (ETI) in Upper Gastrointestinal Bleed (UGIB): A Retrospective Study
Abhilash Perisetti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lucio Lombardo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
MER Darnell et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Share Paper
